Spero Therapeutics (SPRO) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Spero Therapeutics (SPRO) over the last 10 years, with Q3 2025 value amounting to $56.3 million.
- Spero Therapeutics' Shares Outstanding rose 367.74% to $56.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.3 million, marking a year-over-year increase of 367.74%. This contributed to the annual value of $54.6 million for FY2024, which is 300.73% up from last year.
- Spero Therapeutics' Shares Outstanding amounted to $56.3 million in Q3 2025, which was up 367.74% from $56.2 million recorded in Q2 2025.
- In the past 5 years, Spero Therapeutics' Shares Outstanding registered a high of $56.3 million during Q3 2025, and its lowest value of $29.7 million during Q1 2021.
- For the 5-year period, Spero Therapeutics' Shares Outstanding averaged around $46.5 million, with its median value being $52.6 million (2023).
- Its Shares Outstanding has fluctuated over the past 5 years, first surged by 6193.31% in 2022, then surged by 103.61% in 2023.
- Quarter analysis of 5 years shows Spero Therapeutics' Shares Outstanding stood at $32.4 million in 2021, then soared by 61.93% to $52.5 million in 2022, then rose by 1.04% to $53.0 million in 2023, then increased by 3.01% to $54.6 million in 2024, then grew by 3.15% to $56.3 million in 2025.
- Its Shares Outstanding was $56.3 million in Q3 2025, compared to $56.2 million in Q2 2025 and $55.9 million in Q1 2025.